RxDoctor Payments DataLook up a doctor →

Mark Leiker, MD

Family Medicine · Wichita, KSNPI 1881698348

Payments from drug & device makers

$19,744in general payments, 2019–2025

Across 1,969 payments — averaging $10.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Pfizer$2K
  • AstraZeneca$1K
  • Amgen$946
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk305$2,185
AbbVie(2 entities)350$2,175
Lilly USA, LLC197$1,958
Pfizer244$1,751
AstraZeneca56$1,476
Amgen(2 entities)108$946
Supernus Pharmaceuticals, Inc.39$821
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC52$806
GSK67$689
Amarin Pharma, Inc.50$641
Johnson & Johnson73$622
Sanofi-aventis U.S. LLC52$596
Boehringer Ingelheim35$421
Antares Pharma, Inc.25$382
Radius Health, Inc.21$332
Abbott22$310
Sunovion Pharmaceuticals Inc.25$258
Novartis29$235
Idorsia Pharmaceuticals US Inc9$235
Lundbeck LLC18$228
Eisai Inc.18$208
Biohaven Pharmaceutical Holding Company Ltd.28$201
Dexcom, Inc.10$178
Sumitomo Pharma America, Inc.13$177
Biohaven Pharmaceuticals, Inc.22$159
Bayer7$120
Almatica Pharma LLC5$103
Vanda Pharmaceuticals Inc.2$96
Nevro Corp.4$93
Merck6$91
Teva Pharmaceuticals USA, Inc.6$86
Takeda Pharmaceuticals U.S.A., Inc.6$85
Globus Medical2$84
Otsuka America Pharmaceutical, Inc.4$80
Esperion Therapeutics, Inc.5$74
Daiichi Sankyo Inc.5$71
Ironshore Pharmaceuticals Inc.1$69
Corcept Therapeutics4$68
Medtronic2$60
Arbor Pharmaceuticals, Inc.4$54
E.r. Squibb & Sons, L.L.C.3$48
Insulet Corporation2$44
Axsome Therapeutics, Inc.3$43
Gilead2$34
Xeris Pharmaceuticals, Inc.2$33
Shire North American Group Inc2$28
Biogen2$28
Astellas Pharma US Inc2$27
Cranial Technologies, Inc2$26
Neos Therapeutics, LP2$26
Halozyme Inc1$24
Paratek Pharmaceuticals, Inc.1$16
Nestle Healthcare Nutrition Inc.1$16
IBSA Pharma Inc.1$15
Alnylam Pharmaceuticals Inc.1$15
Nalpropion Pharmaceuticals LLC1$14
Exact Sciences1$13
Genentech USA, Inc.1$13
Ironwood Pharmaceuticals, Inc1$13
Upsher-smith Laboratories LLC1$12

How this compares

$19,744 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$159,900
Medicare patients
435
Services billed
2,905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →